Researcher.Life Logo

CNS Neuroscience and Therapeutics : Impact Factor & More

eISSN: 1755-5949pISSN: 1755-5930
JournalOpen Access

Aims and Scope of CNS Neuroscience and Therapeutics

CNS Neuroscience & Therapeutics is a bimonthly medical journal published 1995 by Wiley-Blackwell addressing topics in neurology and central nervous system therapeutic pharmacology. It was established in 1995 as CNS Drug Reviews and obtained its current title in 2008. Less

Key Metrics

CiteScore
8.9
Eigenfactor
0.005 - 0.01
Impact Factor
5 - 10
SJR
Q1Pharmacology
SNIP
1.34
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on CNS Neuroscience and Therapeutics

CNS Neuroscience and Therapeutics Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher WILEY
Language English
Frequency Monthly
Article Processing ChargesEUR 2150 | GBP 1900 | USD 2530
Publication Time14
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1995
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 14
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in CNS Neuroscience and Therapeutics ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in CNS Neuroscience and Therapeutics

Multi\u2010Target\u2010Directed Ligands (MTDLs) as Potential Therapeutic Candidates Targeting Multiple Pathogenic Factor of Alzheimer's Disease
  • 18 May 2026
  • CNS Neuroscience & Therapeutics
Sugammadex Vs. Neostigmine for Cerebral Perfusion During Emergence From General Anesthesia in Patients Undergoing Carotid Endarterectomy: A Double\u2010Blind Randomized Controlled Trial
  • 18 May 2026
  • CNS Neuroscience & Therapeutics
Association Between Differences in Estimated GFR by Creatinine Vs. Cystatin C and Stroke Outcomes: Results From the Third China National Stroke Registry
  • 18 May 2026
  • CNS Neuroscience & Therapeutics
The Fidelity Paradox in Spinal Cord Injury: Reframing Biomechanical Mimicry and Neurobiological Relevance for Clinical Translation
  • 16 May 2026
  • CNS Neuroscience & Therapeutics
Etiopathogenesis of Immune\u2010Mediated Necrotizing Myopathy: A Comprehensive Review of Recent Advances
  • 15 May 2026
  • CNS Neuroscience & Therapeutics
Emerging Roles of Adenosine Metabolism in Astrocytes During Brain Injury
  • 15 May 2026
  • CNS Neuroscience & Therapeutics
Multi\u2010Target\u2010Directed Ligands (MTDLs) as Potential Therapeutic Candidates Targeting Multiple Pathogenic Factor of Alzheimer's Disease
  • 18 May 2026
  • CNS Neuroscience & Therapeutics
Sugammadex Vs. Neostigmine for Cerebral Perfusion During Emergence From General Anesthesia in Patients Undergoing Carotid Endarterectomy: A Double\u2010Blind Randomized Controlled Trial
  • 18 May 2026
  • CNS Neuroscience & Therapeutics
Association Between Differences in Estimated GFR by Creatinine Vs. Cystatin C and Stroke Outcomes: Results From the Third China National Stroke Registry
  • 18 May 2026
  • CNS Neuroscience & Therapeutics
The Fidelity Paradox in Spinal Cord Injury: Reframing Biomechanical Mimicry and Neurobiological Relevance for Clinical Translation
  • 16 May 2026
  • CNS Neuroscience & Therapeutics
Etiopathogenesis of Immune\u2010Mediated Necrotizing Myopathy: A Comprehensive Review of Recent Advances
  • 15 May 2026
  • CNS Neuroscience & Therapeutics
Emerging Roles of Adenosine Metabolism in Astrocytes During Brain Injury
  • 15 May 2026
  • CNS Neuroscience & Therapeutics

FAQs on CNS Neuroscience and Therapeutics